Literature DB >> 23800510

Cathepsin proteases promote angiogenic sprouting and laser-induced choroidal neovascularisation in mice.

A Bühler1, S Berger, F Bengsch, G Martin, H Han, S Vierkotten, A Pielen, D Boehringer, G Schlunck, S Fauser, H T Agostini, T Reinheckel, A Stahl.   

Abstract

Cysteine cathepsins are a family of proteases involved in intracellular protein turnover and extracellular matrix degradation. Cathepsin B (Ctsb) and cathepsin Z (Ctsz) promote tumorigenesis and Ctsb is a known modulator of tumor angiogenesis. We therefore investigated the angiomodulatory function of these cathepsins in vitro as well as in a mouse model of laser-induced choroidal neovascularization (laser-CNV). Ctsb(-/-), Ctsz(-/-), Ctsb/Ctsz double-knockout (Ctsb/z DKO), and wild type (WT) mice underwent argon laser treatment to induce choroidal neovascularization (CNV). The neovascularized area was quantified individually for each lesion at 14 days after laser coagulation. In vitro the effects of cathepsin inhibitors on angiogenesis were analysed by endothelial cell (EC) spheroid sprouting and EC invadosome assays. Retinas from cathepsin KO mice did not show gross morphological abnormalities. In the laser CNV model, however, Ctsb/z DKO mice displayed a significantly reduced neovascularized area compared to WT (0.027 mm(2) vs. 0.052 mm(2); p = 0.012), while single knockouts did not differ significantly from WT. In line, VEGF-induced EC spheroid sprouting and invadosome formation were not significantly altered by a specific cathepsin B inhibitor alone, but significantly suppressed when more than one cathepsin was inhibited. Our results demonstrate that laser-CNV formation is significantly reduced in Ctsb/z DKO mice. In line, EC sprouting and invadosome formation are blunted when more than one cathepsin is inhibited in vitro. These results reveal an angiomodulatory potential of cathepsins with partial functional redundancies between different cathepsin family members.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMD; CNV; angiogenesis; cathepsin; retina

Mesh:

Substances:

Year:  2013        PMID: 23800510     DOI: 10.1016/j.exer.2013.06.014

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  Sorcin induces gastric cancer cell migration and invasion contributing to STAT3 activation.

Authors:  Huan Tuo; Feng Shu; Sha She; Min Yang; Xiao Qin Zou; Juan Huang; Huai Dong Hu; Peng Hu; Hong Ren; Shi Fang Peng; Yi Xuan Yang
Journal:  Oncotarget       Date:  2017-10-31

2.  Synthesis, Characterization and in vitro Studies of a Cathepsin B-Cleavable Prodrug of the VEGFR Inhibitor Sunitinib.

Authors:  Claudia Karnthaler-Benbakka; Bettina Koblmüller; Marlene Mathuber; Katharina Holste; Walter Berger; Petra Heffeter; Christian R Kowol; Bernhard K Keppler
Journal:  Chem Biodivers       Date:  2018-12-19       Impact factor: 2.408

3.  Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy.

Authors:  Ana Mitrović; Janja Završnik; Georgy Mikhaylov; Damijan Knez; Urša Pečar Fonović; Petra Matjan Štefin; Miha Butinar; Stanislav Gobec; Boris Turk; Janko Kos
Journal:  Cell Mol Life Sci       Date:  2022-01-06       Impact factor: 9.261

4.  Integration of Genome-Wide DNA Methylation and Transcription Uncovered Aberrant Methylation-Regulated Genes and Pathways in the Peripheral Blood Mononuclear Cells of Systemic Sclerosis.

Authors:  Honglin Zhu; Chengsong Zhu; Wentao Mi; Tao Chen; Hongjun Zhao; Xiaoxia Zuo; Hui Luo; Quan-Zhen Li
Journal:  Int J Rheumatol       Date:  2018-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.